ZA9810468B - Heterocyclic compounds for inhibition of gastric acid secretion processes for their preparation and pharmaceutical compositions thereof - Google Patents

Heterocyclic compounds for inhibition of gastric acid secretion processes for their preparation and pharmaceutical compositions thereof

Info

Publication number
ZA9810468B
ZA9810468B ZA9810468A ZA9810468A ZA9810468B ZA 9810468 B ZA9810468 B ZA 9810468B ZA 9810468 A ZA9810468 A ZA 9810468A ZA 9810468 A ZA9810468 A ZA 9810468A ZA 9810468 B ZA9810468 B ZA 9810468B
Authority
ZA
South Africa
Prior art keywords
inhibition
preparation
pharmaceutical compositions
heterocyclic compounds
gastric acid
Prior art date
Application number
ZA9810468A
Other languages
English (en)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA9810468B publication Critical patent/ZA9810468B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9810468A 1997-11-28 1998-11-16 Heterocyclic compounds for inhibition of gastric acid secretion processes for their preparation and pharmaceutical compositions thereof ZA9810468B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704404A SE9704404D0 (sv) 1997-11-28 1997-11-28 New compounds

Publications (1)

Publication Number Publication Date
ZA9810468B true ZA9810468B (en) 1999-05-21

Family

ID=20409181

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810468A ZA9810468B (en) 1997-11-28 1998-11-16 Heterocyclic compounds for inhibition of gastric acid secretion processes for their preparation and pharmaceutical compositions thereof

Country Status (33)

Country Link
US (1) US6518270B1 (da)
EP (1) EP1042324B1 (da)
JP (1) JP2001525322A (da)
KR (1) KR20010032559A (da)
CN (1) CN1142933C (da)
AR (1) AR016972A1 (da)
AT (1) ATE233263T1 (da)
AU (1) AU752187C (da)
BR (1) BR9814755A (da)
CA (1) CA2311798A1 (da)
CZ (1) CZ292349B6 (da)
DE (1) DE69811735T2 (da)
DK (1) DK1042324T3 (da)
EE (1) EE04060B1 (da)
ES (1) ES2191356T3 (da)
HK (1) HK1030216A1 (da)
HU (1) HUP0100601A3 (da)
ID (1) ID24730A (da)
IL (1) IL136145A0 (da)
IS (1) IS5486A (da)
MY (1) MY121032A (da)
NO (1) NO315704B1 (da)
NZ (1) NZ504355A (da)
PL (1) PL340920A1 (da)
PT (1) PT1042324E (da)
RU (1) RU2241000C2 (da)
SE (1) SE9704404D0 (da)
SK (1) SK283904B6 (da)
TR (1) TR200001530T2 (da)
TW (1) TW515798B (da)
UA (1) UA70932C2 (da)
WO (1) WO1999028322A1 (da)
ZA (1) ZA9810468B (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2283012T3 (es) 1996-01-04 2007-10-16 Novartis Vaccines And Diagnostics, Inc. Bacterioferritina de helicobacter pylori.
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
AR025976A1 (es) * 1999-10-08 2002-12-26 Affinium Pharm Inc Inhibidores de fab i.
WO2003088897A2 (en) * 2001-04-06 2003-10-30 Affinium Pharmaceuticals, Inc. Fab i inhibitors
JP2003119140A (ja) * 2001-08-08 2003-04-23 Sankyo Co Ltd ピロロピリダジン化合物を含有する医薬
EP1509526A2 (en) 2002-04-19 2005-03-02 Cellular Genomics Inc. Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof
US7312341B2 (en) 2002-09-09 2007-12-25 Cgi Pharmaceuticals, Inc. 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof
WO2004029057A1 (ja) * 2002-09-25 2004-04-08 Sankyo Company, Limited 内臓痛の治療または予防のための医薬組成物
AU2003266622A1 (en) * 2002-09-25 2004-04-19 Sankyo Company, Limited Medicinal composition for inhibiting increase in blood gastrin concentration
ES2518316T3 (es) 2002-12-06 2014-11-05 Debiopharm International Sa Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia
WO2004072080A1 (en) 2003-02-10 2004-08-26 Cellular Genomics, Inc. Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of hsp90 complex activity
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
EP1608377B1 (en) * 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
US7405295B2 (en) 2003-06-04 2008-07-29 Cgi Pharmaceuticals, Inc. Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
US7393848B2 (en) 2003-06-30 2008-07-01 Cgi Pharmaceuticals, Inc. Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds
US7259164B2 (en) 2003-08-11 2007-08-21 Cgi Pharmaceuticals, Inc. Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
KR20060099524A (ko) 2003-11-03 2006-09-19 아스트라제네카 아베 무증상 위식도 역류의 치료를 위한 이미다조[1,2-a]피리딘유도체
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
KR102152809B1 (ko) 2004-07-28 2020-09-07 다케다 야쿠힌 고교 가부시키가이샤 피롤로〔2,3-c〕피리딘 화합물, 그 제조 방법 및 용도
CA2575345A1 (en) * 2004-08-02 2006-02-09 Altana Pharma Ag 5-substituted 1h-pyrrolo[3,2-b]pyridines
AU2005280740B2 (en) 2004-09-03 2011-04-28 Yuhan Corporation Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
DE602005020957D1 (de) * 2004-09-03 2010-06-10 Yuhan Corp Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellung
ES2426920T3 (es) * 2004-09-03 2013-10-25 Yuhan Corporation Derivados de pirrolo[3,2-B]piridina y procesos para su preparación
CA2578880C (en) 2004-09-03 2013-01-29 Yuhan Corporation Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof
US7777040B2 (en) 2005-05-03 2010-08-17 Cgi Pharmaceuticals, Inc. Certain substituted ureas, as modulators of kinase activity
JP2009507032A (ja) 2005-09-02 2009-02-19 アボット・ラボラトリーズ 新規なイミダゾ系複素環
WO2007067416A2 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
CA2654202A1 (en) * 2006-06-06 2007-12-21 Schering Corporation Imidazopyrazines as protein kinase inhibitors
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ, インク. Fabiインヒビターとしてのアクリルアミド誘導体
EP3255045A1 (en) 2007-02-16 2017-12-13 Debiopharm International SA Salts, prodrugs and polymorphs of fab i inhibitors
JP5496915B2 (ja) 2008-02-13 2014-05-21 シージーアイ ファーマシューティカルズ,インコーポレーテッド 6−アリール−イミダゾ[1,2−a]ピラジン誘導体、その製造方法、及びその使用方法
US8450321B2 (en) 2008-12-08 2013-05-28 Gilead Connecticut, Inc. 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
SI2716157T1 (sl) 2008-12-08 2016-10-28 Gilead Connecticut, Inc., c/o Gilead Sciences, Inc. Imidazopirazinski Syk-inhibitorji
CN102307581B (zh) 2008-12-08 2016-08-17 吉利德康涅狄格股份有限公司 咪唑并哌嗪syk抑制剂
AU2011226689B2 (en) 2010-03-11 2016-09-01 Kronos Bio, Inc. Imidazopyridines Syk inhibitors
TR201909016T4 (tr) 2012-06-19 2019-07-22 Debiopharm Int Sa (E)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)akrilamidin ön ilaç türevleri.
AP2016009007A0 (en) 2013-07-30 2016-01-31 Gilead Connecticut Inc Formulation of syk inhibitors
HUE052090T2 (hu) 2013-07-30 2021-04-28 Kronos Bio Inc A SYK inhibitorok polimorfja
PT3076976T (pt) 2013-12-04 2020-12-07 Kronos Bio Inc Métodos para tratar cancros
GB201321738D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
UY35898A (es) 2013-12-23 2015-07-31 Gilead Sciences Inc ?compuestos inhibidores de syk y composiciones que los comprenden?.
US9290505B2 (en) 2013-12-23 2016-03-22 Gilead Sciences, Inc. Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
SG11201610551TA (en) 2014-07-14 2017-01-27 Gilead Sciences Inc Combinations for treating cancers
AU2017223037B2 (en) 2016-02-26 2022-04-14 Debiopharm International S.A. Medicament for treatment of diabetic foot infections
KR20220070056A (ko) 2017-08-25 2022-05-27 길리애드 사이언시즈, 인코포레이티드 Syk 억제제의 다형체
CA3130848A1 (en) 2019-02-22 2020-08-27 Kronos Bio, Inc. Solid forms of condensed pyrazines as syk inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507294A (en) * 1982-03-08 1985-03-26 Schering Corp. Imidazo[1,2-a]pyrazines
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
IL97931A0 (en) * 1990-04-27 1992-06-21 Byk Gulden Lomberg Chem Fab Pyridazine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5041442A (en) * 1990-07-31 1991-08-20 Syntex (U.S.A.) Inc. Pyrrolo(1,2-a)pyrazines as inhibitors of gastric acid secretion
WO1992006979A1 (de) * 1990-10-15 1992-04-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue diazine
EP0609328B1 (de) * 1991-10-25 1999-04-28 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyrrolo-pyridazine mit magen- und darmschutzwirkungen
PT742218E (pt) * 1994-01-19 2003-02-28 Sankyo Co Derivados de pirrolopiridazina
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9700661D0 (sv) 1997-02-25 1997-02-25 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds

Also Published As

Publication number Publication date
AU752187C (en) 2003-09-18
PL340920A1 (en) 2001-03-12
ATE233263T1 (de) 2003-03-15
CN1142933C (zh) 2004-03-24
RU2241000C2 (ru) 2004-11-27
EE200000315A (et) 2001-10-15
EP1042324A1 (en) 2000-10-11
DE69811735T2 (de) 2003-12-18
SK283904B6 (sk) 2004-04-06
MY121032A (en) 2005-12-30
IS5486A (is) 2000-05-10
DE69811735D1 (de) 2003-04-03
HK1030216A1 (en) 2001-04-27
ES2191356T3 (es) 2003-09-01
JP2001525322A (ja) 2001-12-11
EP1042324B1 (en) 2003-02-26
CZ292349B6 (cs) 2003-09-17
PT1042324E (pt) 2003-06-30
KR20010032559A (ko) 2001-04-25
CN1284078A (zh) 2001-02-14
HUP0100601A2 (hu) 2001-09-28
TW515798B (en) 2003-01-01
IL136145A0 (en) 2001-05-20
AU1356599A (en) 1999-06-16
NZ504355A (en) 2001-12-21
SK6742000A3 (en) 2001-03-12
EE04060B1 (et) 2003-06-16
ID24730A (id) 2000-08-03
NO20002721L (no) 2000-07-28
US6518270B1 (en) 2003-02-11
AR016972A1 (es) 2001-08-01
AU752187B2 (en) 2002-09-12
SE9704404D0 (sv) 1997-11-28
HUP0100601A3 (en) 2002-10-28
CA2311798A1 (en) 1999-06-10
NO20002721D0 (no) 2000-05-26
CZ20001947A3 (cs) 2000-11-15
WO1999028322A1 (en) 1999-06-10
UA70932C2 (uk) 2004-11-15
DK1042324T3 (da) 2003-05-05
BR9814755A (pt) 2000-10-03
TR200001530T2 (tr) 2000-11-21
NO315704B1 (no) 2003-10-13

Similar Documents

Publication Publication Date Title
ZA9810468B (en) Heterocyclic compounds for inhibition of gastric acid secretion processes for their preparation and pharmaceutical compositions thereof
HK1024248A1 (en) Compounds for inhibition of gastric acid secretion
IL116957A0 (en) Substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
HUP0101580A3 (en) Pharmaceutical compositions capable of being gelled
IL129477A0 (en) N-(aryl/heteroaryl)amino acid derivatives pharmaceutical compositions comprising same and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
HUP0000492A3 (en) N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
HU9800291D0 (en) Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus
HUP0105160A3 (en) Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-betha-cyclodextrin or 2-hydroxypropyl-betha-cyclodextrin and method for its preparation and pharmaceutical compositions containing them
HUP0203431A3 (en) Novel heterocyclic compounds and salts thereof and pharmaceutical compositions containing and use of the same
IL113263A0 (en) Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases
IL117620A0 (en) Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
IL141165A0 (en) New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same
SI1105391T1 (en) Imidazo(1,2-a)pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for thier preparation
IL114534A (en) Heterocyclic derivatives of azolones their preparation and pharmaceutical compositions containing them
GB2355657B (en) Inhibitors Of Gastric Acid Secretion
HUP0103134A2 (en) Process for preparation crystalline forms of osanetant and pharmaceutical compositions containing them
SI1042324T1 (en) Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
IL123424A0 (en) Heterocyclic compounds their preparation and pharmaceutical compositions containing them
HUP0001441A3 (en) Process for the preparation of pharmaceutical compositions containing 4-aza-androst-1-ene derivatives
ZA94368B (en) Amino acid derivatives pharmaceutical compositions containing these compound and processes for their preparation
ZA9510066B (en) Compounds for inhibition of gastric acid secretion
AU4527900A (en) Inhibition of gastric acid production and/or secretion
AU1748001A (en) Pharmaceutical composition for treatment of diarrhea
SI0971920T1 (en) Compounds for inhibition of gastric acid secretion
IL114621A0 (en) Derivatives of 6-fluoro-8-difluoromethoxy-substituted quinolonecarboxylic acids theit preparation and pharmaceutical compositions containing them